Men's Health Women's Health Senior's Health Antioxidants Sports Nutrition Diet & Weight Loss Vitamins & Minerals Herbs Specialty Supplements Targeted Supplements Spa Products Anti-Aging Basics Body Systems Body Structure Book Store Pet Health My Recommendation My Favorite Articles Our Most Popular Specials Bargain Basement Brands Free Samples

MSM

Health News Archive 602 - Polycystic Ovary Syndrome
<<back to structure/function index

N-Acetyl Cysteine for Polycystic Ovary Syndrome

One hundred-fifty overweight or obese infertile women (mean age, 29 years; range 18 - 39 years) with polycystic ovary syndrome (PCOS), who had failed to ovulate after treatment with clomiphene citrate were randomly assigned to receive, in double-blind fashion, 600 mg of N-acetylcysteine (NAC) twice a day or placebo along with clomiphene citrate (100 mg/day) for five days starting at day three of the cycle.  Compared with placebo, NAC significantly increased both the ovulation rate (49.3% vs 1.3%, p<0.00006).  No cases of ovarian hyperstimulation syndrome were reported in the NAC group.  Two miscarriages occurred.

Comment by Alan R. Gaby, MD

Clomiphene citrate is frequently used to induce ovulation in women with PCOS.  Approximately 70% of women treated with this drug experience a return of menstruation and ovulation, and 30% become pregnant within three months of treatment.  The results of the present study suggest that the combination of NAC and clomiphene citrate is beneficial for some women with PCOS who have failed to respond to clomiphene citrate alone.  While the mechanism of action of NAC is not known, it may work by improving the insulin resistance that is frequently associated with PCOS.

back to top